Drug Information

Drug General Information
Drug ID
D0S4MQ
Former ID
DNC012863
Drug Name
8-Bromo-6-styryl-naphthalene-2-carboxamidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527320]
Structure
Download
2D MOL

3D MOL
Formula
C19H15BrN2
Canonical SMILES
C1=CC=C(C=C1)C=CC2=CC(=C3C=C(C=CC3=C2)C(=N)N)Br
InChI
1S/C19H15BrN2/c20-18-11-14(7-6-13-4-2-1-3-5-13)10-15-8-9-16(19(21)22)12-17(15)18/h1-12H,(H3,21,22)/b7-6+
InChIKey
QHYGSRQJBXWIGI-VOTSOKGWSA-N
PubChem Compound ID
44392405
Target and Pathway
Target(s) Trypsin Target Info Inhibitor [527320]
KEGG Pathway Neuroactive ligand-receptor interaction
Pancreatic secretion
Protein digestion and absorption
Influenza A
Reactome Activation of Matrix Metalloproteinases
Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways Activation of Matrix Metalloproteinases
References
Ref 527320Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8.Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties.
Ref 527320Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8.Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.